ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 374 filers reported holding ENCOMPASS HEALTH CORP in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $374,786 | +6.2% | 5,580 | +7.1% | 0.04% | 0.0% |
Q2 2023 | $352,789 | +14.4% | 5,210 | -8.6% | 0.04% | +10.8% |
Q1 2023 | $308,266 | -6.6% | 5,698 | +3.3% | 0.04% | -9.8% |
Q4 2022 | $329,877 | +28.4% | 5,515 | -2.8% | 0.04% | +17.1% |
Q3 2022 | $257,000 | -17.6% | 5,675 | +2.0% | 0.04% | -12.5% |
Q2 2022 | $312,000 | -24.1% | 5,564 | -3.7% | 0.04% | -14.9% |
Q1 2022 | $411,000 | +24.5% | 5,779 | +14.4% | 0.05% | +20.5% |
Q4 2021 | $330,000 | +41.6% | 5,052 | +62.5% | 0.04% | +25.8% |
Q3 2021 | $233,000 | -10.0% | 3,108 | -6.3% | 0.03% | -13.9% |
Q2 2021 | $259,000 | -27.7% | 3,317 | -24.2% | 0.04% | -40.0% |
Q1 2021 | $358,000 | +9.8% | 4,375 | +11.1% | 0.06% | -3.2% |
Q4 2020 | $326,000 | +24.9% | 3,938 | -2.1% | 0.06% | +3.3% |
Q3 2020 | $261,000 | +4.0% | 4,022 | -0.6% | 0.06% | -3.2% |
Q2 2020 | $251,000 | +3.7% | 4,046 | +7.1% | 0.06% | -13.9% |
Q1 2020 | $242,000 | +18.6% | 3,779 | +28.1% | 0.07% | +44.0% |
Q4 2019 | $204,000 | – | 2,949 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 396,670 | $27,477,000 | 7.28% |
Endurant Capital Management LP | 163,092 | $11,297,000 | 3.56% |
REINHART PARTNERS, LLC. | 656,158 | $45,452,000 | 3.34% |
RK Capital | 117,590 | $8,145,000 | 3.05% |
HIGH POINTE CAPITAL MANAGEMENT LLC | 27,150 | $1,881,000 | 2.23% |
Wolf Group Capital Advisors | 47,461 | $3,288,000 | 2.16% |
Copeland Capital Management, LLC | 631,346 | $43,734,000 | 1.92% |
Advantage Alpha Capital Partners LP | 100,722 | $6,977,000 | 1.88% |
Rock Springs Capital Management LP | 815,000 | $56,455,000 | 1.78% |
Kalos Management, Inc. | 61,180 | $4,237,000 | 1.54% |